Lipid-lowering therapy in the older adults: are we asking the right questions? - Takeaways - MDSpire

Lipid-lowering therapy in the older adults: are we asking the right questions?

  • By

  • Amal Aïdoud

  • September 25, 2025

  • 0 min

Share

  • 1

    Lipid-lowering therapies for primary prevention in older adults without cardiovascular disease remain controversial and under-researched.

  • 2

    Yang et al.'s study indicates that lipid-lowering therapy may significantly reduce all-cause and cardiovascular mortality in individuals aged ≥75.

  • 3

    Current guidelines emphasize individualized treatment decisions for older adults, considering factors beyond chronological age.

  • 4

    Shared decision-making is crucial, focusing on patient preferences and overall health context rather than rigid age thresholds.

  • 5

    The editorial advocates for a patient-centered approach to cardiovascular prevention, prioritizing quality of life alongside longevity.

Original Source(s)

Lipid-lowering therapy in the older adults: are we asking the right questions?

  • by Amal Aïdoud

  • September 25, 2025

Related Content

Influence of Sarcopenia on Ventricular Remodeling Post-Coronary Artery Bypass Grafting in Aged Individuals with Coronary Heart Disease

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.